DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study

ObjectiveTo evaluate the efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with hepatic arterial infusion chemotherapy (HAIC), donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma (uHCC).MethodsThis multicenter retrospective...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yuanjin Ma, Jian Long, Shangbo Shi, Xinyi Fang, Ruidong Wang, Feng Xiong, Hong Ren, Wei Li, Xuexian Zhang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-05-01
Edice:	Frontiers in Immunology
Témata:	camrelizumab donafenib drug-eluting bead transarterial chemoembolization hepatic arterial infusion chemotherapy hepatocellular carcinoma
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1779170/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!